Navigation Links
CHPA Applauds Pennsylvania's Adoption of Real-Time, Stop-Sale Technology, An Effective Tool in the Fight Against Methamphetamine
Date:7/10/2013

WASHINGTON, July 10, 2013 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the Pennsylvania legislature and Governor Tom Corbett(R) for passage of House Bill 602, legislation requiring real-time, stop-sale technology to enable retailers to block illegal pseudoephedrine purchases right at the point of sale and to provide law enforcement with valuable potential criminal data up to the minute.  Sponsored by state Representative Marguerite Quinn (R-Bucks), the bill lets the Keystone state join 28 other states in the fight against the illegal diversion of cold and allergy medicines containing pseudoephedrine to manufacture methamphetamine.

House Bill 602 brings Pennsylvania online with the majority of states via the National Precursor Log Exchange (NPLEx) system. NPLEx is a proven tool in the fight against methamphetamine production that has blocked tens of thousands of illegal sales across the country.

"While the vast majority of consumers purchase cold and allergy medicines legally, some criminals attempt to obtain illegal quantities of pseudoephedrine in order to manufacture methamphetamine," said Scott Melville, president and CEO, of the Consumer Healthcare Products Association. "NPLEx gives retailers the power to block these illegal purchases at the register before they happen, giving communities and Pennsylvania law enforcement a new and critical tool in stopping the illegal sale of these medicines to criminals."

NPLEx provides a secure, interconnected electronic logbook system that tracks and logs every pseudoephedrine sale in every store at the precise moment it is happening. When a purchase is made, the system advises retailers when to refuse a sale based on an individual's purchase record elsewhere in the state and is the only system that can block the illegal sale in real-time and across state lines.

"Governor Corbett, Representative Quinn, and the Pennsylvania legislature are to be commended for choosing a proven method for curbing methamphetamine production that targets criminals and protects responsible consumers' access to popular and reliable cold and allergy medicines," said Melville. "Passage of SB 602 is a significant victory for Pennsylvania citizens, employers, law enforcement officials and healthcare providers."   

www.chpa.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
2. CHPA Applauds Alabamas Adoption Of HB 363
3. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
4. CHPA Applauds Arizonas Adoption Of HB 2263
5. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
6. Obesity Care Continuum (OCC) Applauds FDA for Approval of New Obesity Drug
7. Novation Applauds FDAs Unique Device Identification Rule
8. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
9. Mylan Applauds Signing of Landmark "Food and Drug Administration Safety and Innovation Act"
10. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
11. CRN Applauds Introduction Of Designer Anabolic Steroid Control Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017 The National University of Singapore ... analytics company, signed a Memorandum of Understanding (MOU) ... in the region. Under this ... and Technology (BIGHEART) at NUS and Holmusk will ... to healthcare IT and medical device development. These ...
(Date:3/27/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... toxicology and efficacy studies. The company is harnessing the ... protein, MAGE A, in an effort to find a ... After 4 weeks of treatment in transgenic mice, ... toxicity in a full toxicology report of various organs. ...
(Date:3/27/2017)... March 27, 2017  Sanderling Ventures, portfolio company, ... a division of Johnson & Johnson. Torax manufactures and ... treatment of gastro-esophageal reflux disease (GERD). The LINK ... technology and the procedure is currently available in ... Torax Medical was founded by Sanderling Ventures, Mayo ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... science and clinical practice of radiosurgery, announced today the publication of a ... registry established to standardize data collection from patients treated with stereotactic radiosurgery ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian ... Medical doctors and PhD scientists will speak to the press on behalf of over ... of an independent vaccine safety commission. , WHERE: , Zenger Room, National Press ...
(Date:3/28/2017)... ORANGE, Calif. (PRWEB) , ... March 28, 2017 ... ... of its leading physicians, Paul Yost, will begin serving as new board chair ... earlier this month. Yost will serve the remainder of soon-to-be former chair Mark ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO ... found in power plant water and steam. , Chlorides and sulfates cause pitting ... leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive porcelain ... smile.” The National Association of Dental Laboratories (NADL) is informing dentists about the ... of when utilizing dental laboratories and technicians that create these veneers. , ...
Breaking Medicine News(10 mins):